Literature DB >> 17523988

Combined immunomodulating properties of 3,4-methylenedioxymethamphetamine (MDMA) and cannabis in humans.

Roberta Pacifici1, Piergiorgio Zuccaro, Magí Farré, Sandra Poudevida, Sergio Abanades, Simona Pichini, Klaus Langohr, Jordi Segura, Rafael de la Torre.   

Abstract

AIMS: Cell-mediated immune function and the occurrence of mild infectious diseases was investigated. Participants Polydrug consumers of 3,4-methylenedioxymethamphetamine (MDMA) and cannabis (n = 37) compared to cannabis users only (n = 23) and control group (n = 34).
DESIGN: A longitudinal prospective study with three cross-sectional evaluations at time 0 and at 6 months and 1 year was performed.
FINDINGS: At baseline, a significant decrease in interleukin (IL)-2 and an increase in anti-inflammatory transforming growth factor (TGF)-beta1, together with a decrease in the number of total lymphocytes, CD4 and natural killer (NK) cells were observed in the MDMA-cannabis group, with intermediate alterations in the cannabis group. Immune alterations observed at baseline were sustained over time. No differences were found between regular and occasional MDMA users. A significantly higher rate of mild infections in regular MDMA-cannabis users compared with occasional MDMA-cannabis users and the remaining groups was observed.
CONCLUSIONS: The present data confirm that long-term alterations in immunological homeostasis may result in general health status impairment and subsequent increased susceptibility to infection and immune-related disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17523988     DOI: 10.1111/j.1360-0443.2007.01805.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  9 in total

1.  Basal functioning of the hypothalamic-pituitary-adrenal (HPA) axis and psychological distress in recreational ecstasy polydrug users.

Authors:  Mark A Wetherell; Catharine Montgomery
Journal:  Psychopharmacology (Berl)       Date:  2013-11-05       Impact factor: 4.530

Review 2.  Immunoactive effects of cannabinoids: considerations for the therapeutic use of cannabinoid receptor agonists and antagonists.

Authors:  William E Greineisen; Helen Turner
Journal:  Int Immunopharmacol       Date:  2010-02-25       Impact factor: 4.932

3.  3,4-methylenedioxymethamphetamine (MDMA--Ecstasy) decreases neutrophil activity through the glucocorticoid pathway and impairs host resistance to Listeria monocytogenes infection in mice.

Authors:  V Ferraz-de-Paula; A Ribeiro; J Souza-Queiroz; M L Pinheiro; J F Vecina; D P M Souza; W M Quinteiro-Filho; R L M Moreau; M L S Queiroz; J Palermo-Neto
Journal:  J Neuroimmune Pharmacol       Date:  2014-08-12       Impact factor: 4.147

4.  Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters.

Authors:  Michelle Sexton; Eiron Cudaback; Rehab A Abdullah; John Finnell; Laurie K Mischley; Mary Rozga; Aron H Lichtman; Nephi Stella
Journal:  Inflammopharmacology       Date:  2014-08-19       Impact factor: 4.473

Review 5.  Methylenedioxymethamphetamine ('Ecstasy')-induced immunosuppression: a cause for concern?

Authors:  Noreen T Boyle; Thomas J Connor
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

6.  Adolescent self-administration of the synthetic cannabinoid receptor agonist JWH-018 induces neurobiological and behavioral alterations in adult male mice.

Authors:  Giulia Margiani; Maria Paola Castelli; Nicholas Pintori; Roberto Frau; Maria Grazia Ennas; Valeria Orrù; Valentina Serra; Edoardo Fiorillo; Paola Fadda; Giovanni Marsicano; Maria Antonietta De Luca
Journal:  Psychopharmacology (Berl)       Date:  2022-08-09       Impact factor: 4.415

Review 7.  Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities.

Authors:  Attila Szabo
Journal:  Front Immunol       Date:  2015-07-14       Impact factor: 7.561

Review 8.  The Link between Cannabis Use, Immune System, and Viral Infections.

Authors:  Sanjay B Maggirwar; Jag H Khalsa
Journal:  Viruses       Date:  2021-06-09       Impact factor: 5.048

Review 9.  Inflammatory Biomarkers in Addictive Disorders.

Authors:  Alvaro Morcuende; Francisco Navarrete; Elena Nieto; Jorge Manzanares; Teresa Femenía
Journal:  Biomolecules       Date:  2021-12-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.